DapagliFLOzin in Renal AL Amyloidosis (FLORAL)

Clinical trial NCT06420167 · RECRUITING

Trial details

NCT number: NCT06420167
Sponsor: Barbara Ann Karmanos Cancer Institute
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Renal AL Amyloidosis

Start date: 2024-07-11
Primary completion: 2027-04-01
Enrollment: 20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.